Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2012
10/26/2012CA2829264A1 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
10/26/2012CA2825971A1 5-(phenyl/pyridinyl-ethinyl) -2 -pyridine/ 2 -pyrimidine-carborxamides as mglur5 modulators
10/25/2012US20120271051 Method for producing 2-(2-aminopyrimidin-4-yl)-1h-indole-5-carboxylic acid derivatives
10/25/2012US20120270877 IRE-1alpha INHIBITORS
10/25/2012US20120270875 Pyrimidine amide compounds
10/25/2012US20120270863 Fused ring analogues of anti-fibrotic agents
10/25/2012US20120270858 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
10/25/2012US20120270852 Phenyl or pyridinyl-ethynyl derivatives
10/25/2012US20120270237 Methods for the identification of kinase interacting molecules and for the purification of kinase proteins
10/24/2012EP2514748A1 2,4-diaminoquinazolines for spinal muscular atrophy
10/24/2012EP2514423A2 Method of treatment of age-related macular degeneration (AMD)
10/24/2012EP2513065A1 Process for the preparation of key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
10/24/2012EP2513057A1 Sphingosine kinase inhibitors
10/24/2012EP2512482A1 2-aldoximino-5-fluoropyrimidine derivatives
10/24/2012CN102753535A Quinazolines as potassium ion channel inhibitors
10/24/2012CN102753534A Process for the preparation of key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
10/24/2012CN102746260A Method for preparing benzofuran-2-(3H)-one
10/24/2012CN102746242A Synthesis method of 6, 7-substituted-4-aniline quinazoline
10/24/2012CN102746241A 2, 3, 5-trisubstituted benzamide compound, and preparation method and application thereof
10/24/2012CN102746240A Anti-infective pyrimidines and uses thereof
10/24/2012CN102746239A Uracil or thymine derivative for treating hepatitis c
10/24/2012CN102746238A Preparation method of pyrimethanil
10/24/2012CN102746237A Preparation method of 4,6-dichloropyrimidine
10/24/2012CN102153519B Preparation method of quinazoline derivative
10/24/2012CN101654565B Method for preparing isoindoline pigment
10/23/2012US8293902 Quinazoline compounds
10/23/2012US8293757 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
10/23/2012US8293752 Compounds useful as Raf kinase inhibitors
10/23/2012US8293751 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/23/2012CA2548058C Herbicidal pyrimidines
10/23/2012CA2537962C Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6 -enoicacid] calcium salt
10/18/2012WO2012142329A1 Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors
10/18/2012WO2012141197A1 Organic electroluminescence element
10/18/2012WO2012141185A1 Organic light-emitting element, organometallic complex, light-emitting device, electronic appliance, and lighting device
10/18/2012WO2012140642A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/18/2012WO2012139912A1 Equilibrated dynamic mixtures to control the release of perfuming aldehydes and ketones
10/18/2012WO2012139499A1 Urea compounds as well as preparation methods, intermediates and uses thereof
10/18/2012US20120264756 Phosphatidylcholine Transfer Protein Inhibitors
10/18/2012US20120264728 Amino-heteroaryl derivatives as hcn blockers
10/18/2012CA2832919A1 Compounds, compositions, and therapeutic uses thereof
10/18/2012CA2832822A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/17/2012EP2509963A1 Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea and salts thereof.
10/17/2012CN102731485A 4-(substituted phenylamino)quinazoline derivative, its preparation method, pharmaceutical composition and application
10/17/2012CN102731416A 1-(aryl methyl)-quinazoline-2,4-dione as PARP inhibitor and its application
10/17/2012CN102731415A Quinazoline-4-piperazine dithioformate and preparation method and purpose thereof
10/17/2012CN102731414A Method for preparing 4-[(4-chloro-2-pyrimidinyl) amino] cyanophenyl
10/17/2012CN102731413A Urea compound and its preparation method, intermediate and use
10/17/2012CN102731412A Synthetic method of 2,4-dichloro-5-pyrimidine formaldehyde
10/17/2012CN102731411A Preparation of 4-alkyl-6-aryl-3,4-dihydropyrimidine-2-thioketone and application of same as antidepressant drug
10/17/2012CN102731343A Nitrogen atom-polysubstituted micro-molecular organic aryl amide compounds and derivatives thereof, and application and preparation method thereof
10/17/2012CN102127031B Ephedrine compound quaternary ammonium and synthetic method and application thereof
10/17/2012CN101899008B N-substituted pyrimidine sulfonyl-substituted benzamide type small molecular inhibitor for Bcl-2 protein and application thereof
10/17/2012CN101208307B Process for preparing amorphous rosuvastatin calcium free of impurities
10/16/2012USRE43748 Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same
10/16/2012US8288539 Dipeptidyl peptidase inhibitors
10/16/2012US8288538 Pyridine derivatives and pyrimidine derivatives (3)
10/16/2012US8288537 Caspase inhibitors and uses thereof
10/16/2012US8288420 Compounds capable of activating cholinergic receptors
10/16/2012US8288400 Compositions useful as inhibitors of protein kinases
10/16/2012US8288394 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative
10/16/2012US8288318 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides
10/16/2012CA2563895C Disalt inhibitors of il-12 production
10/16/2012CA2485681C Ccr9 inhibitors and methods of use thereof
10/11/2012WO2012137958A1 Organic compound, charge transport material, composition containing said compound, organic electroluminescent element, display device, and lighting device
10/11/2012WO2012136834A1 Pyrimidine derivatives for the treatment of viral infections
10/11/2012WO2012136120A1 Aryl acrylamide compound and use thereof in preparing immunosuppressant
10/11/2012WO2012136099A1 4-(substituted phenylamino)quinazoline derivative and preparation method therefor, pharmaceutical composition and use thereof
10/11/2012WO2012083306A3 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
10/11/2012US20120258975 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof
10/11/2012US20120258968 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
10/11/2012CA2832685A1 Pyrimidine derivatives for the treatment of viral infections
10/10/2012EP2508514A1 Process for preparing amorphous rosuvastatin calcium free of impurities
10/10/2012EP2508185A1 Anti-tumor effect potentiator
10/10/2012EP2507216A1 Method for producing (4,6-dimethylpyrimidine-2-yl)-phenylamine (pyrimethanil)
10/10/2012CN1880317B Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/10/2012CN102725274A Antimicrobial compounds and methods of making and using the same
10/10/2012CN102718775A Macrocyclic quinazoline derivatives as antiproliferative agents
10/10/2012CN102718721A 4,4-disubstituted-dihydrogen-2(1H)-quinazolone or thioketone compound, synthetic method and application thereof
10/10/2012CN102718720A Method for preparing 4-[(4,6-dichloro-2-pyrimidyl) amino] cyanophenyl
10/10/2012CN102718719A Heterocyclic substituted urea compounds and preparation method thereof
10/10/2012CN102718701A Aryloxy dihalide propylene ether compound and application thereof
10/10/2012CN102716757A Supported catalyst, as well as preparation method and application thereof in synthesis of 3,4-dihydropyrimidine-2-ketone
10/10/2012CN102153518B Preparation method of Gefitinib
10/10/2012CN102030716B Method for preparing gefitinib
10/10/2012CN101541764B Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101077867B Bis-aryl sulfonamides
10/10/2012CN101018772B Neurologically-active compounds
10/09/2012US8283385 Reversibly switchable surfactants and methods of use thereof
10/09/2012US8283356 2,4- Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors
10/09/2012US8283355 Pyrimidine derivatives as POSH and POSH-AP inhibitors
10/09/2012CA2674803C Quinazoline derivatives as angiogenesis inhibitors
10/09/2012CA2550598C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method and their use in therapy
10/09/2012CA2507100C 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
10/04/2012WO2012135801A1 Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
10/04/2012WO2012135800A1 Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase
10/04/2012WO2012135781A1 Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
10/04/2012WO2012135779A1 Combinations of akt and mek inhibitor compounds, and methods of use
10/04/2012WO2012135759A1 Combinations of akt inhibitor compounds and abiraterone, and methods of use
10/04/2012WO2012135753A1 Combinations of akt inhibitor compounds and erlotinib, and methods of use
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 427